A Study of Oral Tebipenem Pivoxil Hydrobromide (TBP-PI-HBr) Compared to Intravenous Imipenem-cilastatin in Participants With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
85 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Medical Facility
Buenos Aires, Argentina
- Medical Facility
Córdoba, Argentina
- Medical Facility
La Plata, Argentina
- Medical Facility
Mendoza, Argentina
- Medical Facility
San Miguel de Tucumán, Argentina
- Medical Facility
Villa Regina, Argentina
- Medical Facility
Banja Luka, Bosnia and Herzegovina
- Medical Facility
Sarajevo, Bosnia and Herzegovina
- Medical Facility
Tuzla, Bosnia and Herzegovina
- Medical Facility
Barueri, Brazil
- Medical Facility
Campinas, Brazil
- Medical Facility
Curitiba, Brazil
- Medical Facility
Porto Alegre, Brazil
- Medical Facility
São José do Rio Preto, Brazil
- Medical Facility
Blagoevgrad, Bulgaria
- Medical Facility
Dobrich, Bulgaria
- Medical Facility
Gabrovo, Bulgaria
- Medical Facility
Lom, Bulgaria
- Medical Facility
Pleven, Bulgaria
- Medical Facility
Plovdiv, Bulgaria
- Medical Facility
Rousse, Bulgaria
- Medical Facility
Shumen, Bulgaria
- Medical Facility
Sliven, Bulgaria
- Medical Facility
Sofia, Bulgaria
- Medical Facility
Varna, Bulgaria
- Medical Facility
Slavonski Brod, Croatia
- Medical Facility
Split, Croatia
- Medical Facility
Zagreb, Croatia
- Medical Facility
Čakovec, Croatia
- Medical Facility
Kohtla-Järve, Estonia
- Medical Facility
Pärnu, Estonia
- Medical Facility
Tallinn, Estonia
- Medical Facility
Tartu, Estonia
- Medical Facility
Võru, Estonia
- Medical Facility
Tbilisi, Georgia
- Medical Facility
Alexandroupoli, Greece
- Medical Facility
Athens, Greece
- Medical Facility
Ioannina, Greece
- Medical Facility
Pátrai, Greece
- Medical Facility
Thessaloniki, Greece
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 21 Dec 2023
- Primary completion
- 27 Jan 2025
- Completion
- 6 Feb 2025
- Last update posted
- 10 Mar 2026
- Registered enrollment
- 1,690
- Registry id
- NCT06059846
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.